Bitcoin outperforms S&P 500 with 60% annual return
The risk-reward ratio of Bitcoin (BTC) has been described as being in a "different universe" by a new study conducted by Fidelity Investments.
The cryptocurrency showed a 60% annual return over 69 standard deviations for volatility from 2020 to October 29, 2023. The research points to Bitcoin's strong performance despite its high volatility, highlighting the potential rewards of investing in the digital asset.
Fidelity's study also compared Bitcoin's performance with other market indices. The stock market's S&P 500 (SPX) stood out as the second-best performing index during the same period. However, it did not match Bitcoin's impressive returns, demonstrating the growing appeal of cryptocurrency investments.
On the other hand, Chinese markets yielded negative returns over the same timeframe. This situation stands in sharp contrast to Bitcoin's performance and further emphasizes the potential reward of investing in cryptocurrencies despite their inherent volatility.
Fidelity's research serves as a reminder of the shifting dynamics in global investment strategies. As investors seek higher returns, they are increasingly turning to cryptocurrencies like Bitcoin, despite their high volatility. This shift has also been reflected in Bitcoin's strong performance over the last few years.
In conclusion, Fidelity's study reveals that Bitcoin outperformed traditional market indices like the S&P 500 from 2020 to the end of October 2023. Despite its high volatility, Bitcoin's impressive returns highlight its potential as an investment asset and its growing acceptance in mainstream finance.
News Source: 12punto
Most Read
Striking picture for Özgür Özel's 'New Party'
Özgür Özel gives a dated response regarding the number of resignations
Forest fire in Antalya brought under control
The PKK opening and Özgür Özel’s path!..
Houthis strike Saudi-owned tanker
How did the newspapers view Özgür Özel's farewell to the CHP?
What did the CHP do?
Özel’s new party move in the world press
The New CHP, against CEHAPE
From self-efficacy to despair